OSN Europe: Awareness of antibiotic resistance growing among European ophthalmologists, but old habits hard to eradicate

The WHO has launched World Antibiotic Awareness Week, taking place Nov. 16 to 22. The aim of this new initiative is to increase awareness of the emerging global problem of antibiotic resistance and “to encourage best practices among the general public, health workers and policy makers,” the WHO said in a press release. World Antibiotic Awareness Week is part of a global action plan endorsed by the World Health Assembly in May, with the motto “Antibiotics: Handle with Care.”“If we want to preserve the precious potential of antibiotics, which have saved millions of lives over the past 70 years, we must take care to use them responsibly and wisely,” Andrzej Grzybowski, MD, PhD, professor of ophthalmology at University of Warmia and Mazury and head of the department of ophthalmology at Poznan City Hospital, Poland, said.

NovaBay Declares Reverse Stock Split

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) (“NovaBay” or the “Company”), a biopharmaceutical company focusing on commercializing and developing non-antibiotic antimicrobial products for the global eye care market, today announced that, pursuant to authorization provided by the Company’s stockholders at the Company’s December 11, 2015, special stockholder meeting, and in order to meet the continued listing standards of the NYSE MKT, the Company’s Board of